Search Results 10 matching record(s)

Circadian Variation in QT Interval Demonstrating Assay Sensitivity in a Phase 1 Clinical Trial Peter John Bourdillon Drug Information Journal 2010 : 44(01) View Abstract Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials Rahul Bhattacharya, Antanu Biswas Drug Information Journal 2010 : 44(01) View Abstract Rationale for Sponsor-unblinded Phase 1 Trials: Challenging the Doubleblind Paradigm Jitendra Ganju, Clapton Dias Drug Information Journal 2010 : 44(01) View Abstract Leveraging Technology to Increase Efficiency and Quality for Regulatory SUbmissions Terri M Booth-Genthe, Patricia Sichort Drug Information Journal 2010 : 44(01) View Abstract Standard Operating Procedures (SOPs): How Companies Can Determine Which Documents THey Must Put in Place Michael R. Hamrell, Janet Gough Drug Information Journal 2010 : 44(01) View Abstract Biogeneric Regulatory Policies in China and India: A Comparison Study Jeffery W. Guise, Benjamin M. Carson Drug Information Journal 2010 : 44(01) View Abstract Discussion Based on the Survey Results of Authorities Inquiries During NDA Review in Japan Reiko Numazaki, Yutaka Kawakami, Chikara Kikuchi, Hirofumi Sone, Minako Kasuya, Kazumi Sunamura Drug Information Journal 2010 : 44(01) View Abstract Mentoring in the Pharmaceutical Industry: Developing an Effective Program for a Field-based Medical Team Barb Schreiner, Jimmy Black Drug Information Journal 2010 : 44(01) View Abstract

1 - 8 of 10 results |    Previous |  Next